Durolane Versus Methylprednisolone in Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

November 30, 2008

Conditions
Knee Osteoarthritis
Interventions
DEVICE

Durolane is a device, methylprednisolone in a drug

single intraarticular injection

Trial Locations (23)

11360

Ortopediska huset, Stockholm

T2P 3C5

Alberta Bone & Joint Health Institute, Calgary

A1B 3E1

Nexus Clinical Research, St. John's

B3H 4M2

Orthopaedic & Sport Medicine Institute of Nova Scotia, Halifax

B0J2C0

Dr. Wilson, Lunenburg

B3H 3A7

QEII Health Sciences Centre-New Halifax Infirmary, Halifax

L8N 1Y2

Charlton Medical Centre, Hamilton

L8N 2B6

MAC Research Inc., Hamilton

N6A 3K7

Fowler Kennedy Sport Medicine Clinic, London

L5M 2V8

Credit Valley Rheumatology, Mississauga

L3Y 3R7

The Arthritis Program Research Group, Newmarket

K9J 6X2

Dr. Dobson, Peterborough

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5S 1B2

Sport C.A.R.E. Women's College Hospital, Toronto

G1W4R4

Centre de Rhumatologie St-Louis, Saint-Foy

S7K 0H6

Saskatoon Osteoporosis Centre, Saskatoon

411 37

Läkargruppen Kristinelund, Gothenburg

121 77

Ortopediska huset, Johanneshov

211 36

Läkarhuset Ellenbogen, Malmo

SE5 9RS

Kings College Hospital - Department of Rheumatology, London

NE1 4LP

Newcastle University Clinical Research FacilityRoyal Victoria Infirmary, Newcastle

SY10 7AG

Robert Jones and Agnes Hunt Orthopaedic & District Hospital - Institute of Orthopaedics, Oswestry

SO16 6YD

Southampton General Hospital - MRC Epidemiology Resource Center, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY